Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(adalimumab)
6,657 results
  • [Clinical and epidemiological profile of pediatric uveitis, course of inflammatory uveitis treated with anti-TNF alpha]. [Journal Article]
  • JFJ Fr Ophtalmol 2018 May 16
  • Osswald D, Rameau AC, … Sauer A
  • CONCLUSIONS: Diagnostic criteria based adult systemic disease are sometimes inappropriate for children. The advent of anti-TNFα appears to improve the visual prognosis of inflammatory uveitis resistant to conventional immunosuppressant therapy, but we still need to perfect protocols for their use.There are neither standardized etiological assessment nor clear diagnostic and therapeutic protocols for children. TNFα inhibitors are more effective in controlling inflammation in severe pediatric uveitis.
  • Juvenile idiopathic arthritis-associated uveitis. [Review]
  • BPBest Pract Res Clin Rheumatol 2017; 31(4):517-534
  • Sen ES, Ramanan AV
  • Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in children and JIA-associated uveitis its most frequent extra-articular manifestation. The uveitis is potentially sight-threate...
  • Biologics in SAPHO syndrome: A systematic review. [Review]
  • SASemin Arthritis Rheum 2018 Apr 17
  • Daoussis D, Konstantopoulou G, … Liossis SN
  • CONCLUSIONS: In SAPHO patients not responding to conventional treatment, TNF blockers appear to be the first choice. In patients failing TNF blockers, IL-1 inhibitors and biologics targeting the IL-17/IL-23 axis could be used.
New Search Next